Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,990 | 12,660 | 8,500 | 2,700 | 4,670 |
| Other current assets | 68 | 270 | 480 | 620 | 330 |
| TOTAL | $10,640 | $12,930 | $8,980 | $3,320 | $5,000 |
| Non-Current Assets | |||||
| PPE Net | 640 | 830 | 830 | 1,510 | 1,510 |
| Intangibles | 289 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 71 | 390 | 410 | 450 | 460 |
| TOTAL | $1,000 | $1,220 | $1,240 | $1,960 | $1,970 |
| Total Assets | $11,050 | $13,370 | $9,460 | $3,850 | $5,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 260 | 470 | 440 | 680 | 450 |
| Accrued Expenses | 1,990 | 2,490 | 1,750 | 2,090 | 2,750 |
| TOTAL | $2,250 | $2,960 | $2,190 | $2,780 | $3,210 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6 | 9 | 40 | 10 | 7,610 |
| TOTAL | $6 | $9 | $40 | $10 | $7,610 |
| Total Liabilities | $2,250 | $2,970 | $2,230 | $2,800 | $10,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 579 |
| Common Shares | 150 | 140 | 110 | 70 | 50 |
| Retained earnings | -217,350 | -215,000 | -211,490 | -208,560 | -207,700 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $8,790 | $10,390 | $7,220 | $1,040 | $-5,250 |
| Total Liabilities And Equity | $11,040 | $13,360 | $9,450 | $3,840 | $5,570 |